Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342537 · ClinicalTrials.gov registry record
Genetics of Familial Testicular Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,842
- Enrollment target
NCT00342537: Completed study, sponsored by National Cancer Institute (NCI).
NCT00342537 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,842 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342537 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,842 participants
- Enrollment target
Study Summary
This study is a collaboration between the Clinical Genetics Branch of the National Cancer Institute and the International Testicular Cancer Linkage Consortium (ITCLC). The primary goal of the ITCLC is mapping and cloning susceptibility genes for familial TGCT. The objectives of the current study are to: * Identify the genes responsible for testicular germ cell tumor (TGCT) (testicular cancer) in families with an inherited tendency to develop the disease * Determine if the genes which predispose to developing testicular cancer also increase the risk of other specific types of cancer among first- and second-degree relatives of patients with TGCT * Determine if the microscopic appearance of familial testicular cancers is different from that of non-familial TGCT Patients and family members recruited by the ITCLC in the United Kingdom, the Netherlands, and Norway are eligible for this study. Individuals with the following medical criteria may participate: * Patients with testicular germ cell cancer who have at least one other blood relative with the disease * Family members of patients (first- and second-degree relatives) Participants undergo the following procedures: * Fill out questionnaires for providing information about a history of cancer in all blood relatives, including parents, siblings, children, grandparents, aunts, uncles, and cousins, and a history of undescended testes in male blood relatives. Participants may be asked permission to contact family members to request their help in the study as well. * Provide a blood sample for genetic testing related to TGCT (except in children under 16 years old). * Review of medical records and examination of tumor specimen (patients with TGCT only). * Confirmation of the diagnosis of other types of cancer in these same families (medical records, pathology repots) * Review of the testicular cancer tissue obtained at the time of surgery from members of multiple case families, and comparison of these findings with a se
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,842 participants |
| Start Date | 2004-01-02 |
| Est. Completion | 2020-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00342537
The ClinicalTrials.gov registry entry for NCT00342537 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,842 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00342537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00342537 about?
NCT00342537 is a clinical study titled "Genetics of Familial Testicular Cancer". This study is a collaboration between the Clinical Genetics Branch of the National Cancer Institute and the International Testicular Cancer Linkage Consortium (ITCLC). The primary goal of the ITCLC is mapping and cloning susceptibility genes for familial TGCT. The objectives of the current study are...
What is the current status of trial NCT00342537?
This trial is currently completed. The enrollment target is 1,842 participants. The study started on 2004-01-02. Estimated completion is 2020-07-14.
Who is sponsoring clinical trial NCT00342537?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.